advertisement
Robin AL 26
Showing records 1 to 25 | Display all abstracts from Robin AL81150 Rho-Associated Kinase Inhibitors: Evolving Strategies in Glaucoma Treatment
Schehlein EM
Drugs 2019; 79: 1031-1036
80966 Glaucoma Patient Preferences for Video Education on Eye Drop Technique
Davis SA
Optometry and Vision Science 2019; 96: 325-330
81471 Glaucoma-Associated Visual Task Performance and Vision-Related Quality of Life in South India
Reighard CL
Ophthalmology. Glaucoma 2019; 2: 357-363
81324 Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: 3-Month Data From a Randomized Phase 3 Trial
Asrani S
American Journal of Ophthalmology 2019; 207: 248-257
81471 Glaucoma-Associated Visual Task Performance and Vision-Related Quality of Life in South India
Pillai MR
Ophthalmology. Glaucoma 2019; 2: 357-363
81150 Rho-Associated Kinase Inhibitors: Evolving Strategies in Glaucoma Treatment
Robin AL
Drugs 2019; 79: 1031-1036
81324 Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: 3-Month Data From a Randomized Phase 3 Trial
Robin AL
American Journal of Ophthalmology 2019; 207: 248-257
80966 Glaucoma Patient Preferences for Video Education on Eye Drop Technique
Carpenter DM
Optometry and Vision Science 2019; 96: 325-330
81471 Glaucoma-Associated Visual Task Performance and Vision-Related Quality of Life in South India
Shroff S
Ophthalmology. Glaucoma 2019; 2: 357-363
81324 Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: 3-Month Data From a Randomized Phase 3 Trial
Serle JB
American Journal of Ophthalmology 2019; 207: 248-257
80966 Glaucoma Patient Preferences for Video Education on Eye Drop Technique
Blalock SJ
Optometry and Vision Science 2019; 96: 325-330
81324 Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: 3-Month Data From a Randomized Phase 3 Trial
Lewis RA
American Journal of Ophthalmology 2019; 207: 248-257
80966 Glaucoma Patient Preferences for Video Education on Eye Drop Technique
Budenz DL
Optometry and Vision Science 2019; 96: 325-330
81471 Glaucoma-Associated Visual Task Performance and Vision-Related Quality of Life in South India
Spaeth GL; Schilling SG
Ophthalmology. Glaucoma 2019; 2: 357-363
81324 Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: 3-Month Data From a Randomized Phase 3 Trial
Usner DW
American Journal of Ophthalmology 2019; 207: 248-257
80966 Glaucoma Patient Preferences for Video Education on Eye Drop Technique
Lee C
Optometry and Vision Science 2019; 96: 325-330
81324 Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: 3-Month Data From a Randomized Phase 3 Trial
Kopczynski CC
American Journal of Ophthalmology 2019; 207: 248-257
80966 Glaucoma Patient Preferences for Video Education on Eye Drop Technique
Muir KW
Optometry and Vision Science 2019; 96: 325-330
81471 Glaucoma-Associated Visual Task Performance and Vision-Related Quality of Life in South India
Wizov SS
Ophthalmology. Glaucoma 2019; 2: 357-363
81324 Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: 3-Month Data From a Randomized Phase 3 Trial
Heah T
American Journal of Ophthalmology 2019; 207: 248-257
80966 Glaucoma Patient Preferences for Video Education on Eye Drop Technique
Robin AL
Optometry and Vision Science 2019; 96: 325-330
81471 Glaucoma-Associated Visual Task Performance and Vision-Related Quality of Life in South India
Stein JD
Ophthalmology. Glaucoma 2019; 2: 357-363
81324 Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: 3-Month Data From a Randomized Phase 3 Trial
American Journal of Ophthalmology 2019; 207: 248-257
81471 Glaucoma-Associated Visual Task Performance and Vision-Related Quality of Life in South India
Robin AL
Ophthalmology. Glaucoma 2019; 2: 357-363
80966 Glaucoma Patient Preferences for Video Education on Eye Drop Technique
Sleath B
Optometry and Vision Science 2019; 96: 325-330
